Sharon Stecher
Psychiatric/Mental Health · Maplewood, MONPI 1518142116
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $58.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Vanda Pharmaceuticals Inc.$1K
- Johnson & Johnson$856
- E.r. Squibb & Sons, L.L.C.$522
- AbbVie$445
- plus $2K from 10 others
What the payments were for
- Food & beverage$7,62599%
- Education$961%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $1,691 |
| Otsuka America Pharmaceutical, Inc. | 18 | $1,150 |
| Vanda Pharmaceuticals Inc. | 24 | $1,002 |
| Johnson & Johnson | 15 | $856 |
| E.r. Squibb & Sons, L.L.C. | 8 | $522 |
| AbbVie | 14 | $445 |
| Teva Pharmaceuticals USA, Inc. | 4 | $444 |
| Alkermes, Inc. | 7 | $406 |
| Neurocrine Biosciences, Inc. | 4 | $363 |
| Validus Pharmaceuticals LLC | 3 | $260 |
| Axsome Therapeutics, Inc. | 2 | $234 |
| Avanir Pharmaceuticals, Inc. | 2 | $129 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
| Coloplast | 1 | $75 |
| Lundbeck LLC | 2 | $27 |
| Braeburn Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$1,424
- ARISTADA$955
- Fanapt$732
- COBENFY$482
- ABILIFY MAINTENA$451
- LYBALVI$403
- SPRAVATO$390
- REXULTI$367
- ABILIFY ASIMTUFII$326
- INVEGA SUSTENNA$269
- ARISTADA INITIO$239
- VRAYLAR$238
- UZEDY$234
- Auvelity$234
- Equetro$180
- ONGENTYS$125
- Austedo XR$125
- NUEDEXTA$123
- INVEGA TRINZA$123
- INVEGA$123
How this compares
$7,721 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Maplewood
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
- Kelsey KingsboroughMexico$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.